Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Transdermal Testosterone Market Growth 2022-2028

  • LP 4896750
  • 100 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Transdermal Testosterone will have significant change from previous year. According to our (LP Information) latest study, the global Transdermal Testosterone market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Transdermal Testosterone market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Transdermal Testosterone market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transdermal Testosterone market, reaching US$ million by the year 2028. As for the Europe Transdermal Testosterone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transdermal Testosterone players cover AbbVie, Teva, Perrigo, and Endo Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Testosterone market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Gel

Patch

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Primary Hypogonadism

Hypogonadotropic Hypogonadism

Late-Onset Hypogonadism

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AbbVie

Teva

Perrigo

Endo Pharmaceuticals

Acerus Pharmaceuticals

Lupin

Dr. Reddy's Laboratories

Upsher-Smith Laboratories

Allergan

Cipla Inc.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transdermal Testosterone Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Transdermal Testosterone by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Transdermal Testosterone by Country/Region, 2017, 2022 & 2028

2.2 Transdermal Testosterone Segment by Type

2.2.1 Gel

2.2.2 Patch

2.3 Transdermal Testosterone Sales by Type

2.3.1 Global Transdermal Testosterone Sales Market Share by Type (2017-2022)

2.3.2 Global Transdermal Testosterone Revenue and Market Share by Type (2017-2022)

2.3.3 Global Transdermal Testosterone Sale Price by Type (2017-2022)

2.4 Transdermal Testosterone Segment by Application

2.4.1 Primary Hypogonadism

2.4.2 Hypogonadotropic Hypogonadism

2.4.3 Late-Onset Hypogonadism

2.5 Transdermal Testosterone Sales by Application

2.5.1 Global Transdermal Testosterone Sale Market Share by Application (2017-2022)

2.5.2 Global Transdermal Testosterone Revenue and Market Share by Application (2017-2022)

2.5.3 Global Transdermal Testosterone Sale Price by Application (2017-2022)

3 Global Transdermal Testosterone by Company

3.1 Global Transdermal Testosterone Breakdown Data by Company

3.1.1 Global Transdermal Testosterone Annual Sales by Company (2020-2022)

3.1.2 Global Transdermal Testosterone Sales Market Share by Company (2020-2022)

3.2 Global Transdermal Testosterone Annual Revenue by Company (2020-2022)

3.2.1 Global Transdermal Testosterone Revenue by Company (2020-2022)

3.2.2 Global Transdermal Testosterone Revenue Market Share by Company (2020-2022)

3.3 Global Transdermal Testosterone Sale Price by Company

3.4 Key Manufacturers Transdermal Testosterone Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Transdermal Testosterone Product Location Distribution

3.4.2 Players Transdermal Testosterone Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Transdermal Testosterone by Geographic Region

4.1 World Historic Transdermal Testosterone Market Size by Geographic Region (2017-2022)

4.1.1 Global Transdermal Testosterone Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Transdermal Testosterone Annual Revenue by Geographic Region

4.2 World Historic Transdermal Testosterone Market Size by Country/Region (2017-2022)

4.2.1 Global Transdermal Testosterone Annual Sales by Country/Region (2017-2022)

4.2.2 Global Transdermal Testosterone Annual Revenue by Country/Region

4.3 Americas Transdermal Testosterone Sales Growth

4.4 APAC Transdermal Testosterone Sales Growth

4.5 Europe Transdermal Testosterone Sales Growth

4.6 Middle East & Africa Transdermal Testosterone Sales Growth

5 Americas

5.1 Americas Transdermal Testosterone Sales by Country

5.1.1 Americas Transdermal Testosterone Sales by Country (2017-2022)

5.1.2 Americas Transdermal Testosterone Revenue by Country (2017-2022)

5.2 Americas Transdermal Testosterone Sales by Type

5.3 Americas Transdermal Testosterone Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transdermal Testosterone Sales by Region

6.1.1 APAC Transdermal Testosterone Sales by Region (2017-2022)

6.1.2 APAC Transdermal Testosterone Revenue by Region (2017-2022)

6.2 APAC Transdermal Testosterone Sales by Type

6.3 APAC Transdermal Testosterone Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Transdermal Testosterone by Country

7.1.1 Europe Transdermal Testosterone Sales by Country (2017-2022)

7.1.2 Europe Transdermal Testosterone Revenue by Country (2017-2022)

7.2 Europe Transdermal Testosterone Sales by Type

7.3 Europe Transdermal Testosterone Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transdermal Testosterone by Country

8.1.1 Middle East & Africa Transdermal Testosterone Sales by Country (2017-2022)

8.1.2 Middle East & Africa Transdermal Testosterone Revenue by Country (2017-2022)

8.2 Middle East & Africa Transdermal Testosterone Sales by Type

8.3 Middle East & Africa Transdermal Testosterone Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Transdermal Testosterone

10.3 Manufacturing Process Analysis of Transdermal Testosterone

10.4 Industry Chain Structure of Transdermal Testosterone

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Transdermal Testosterone Distributors

11.3 Transdermal Testosterone Customer

12 World Forecast Review for Transdermal Testosterone by Geographic Region

12.1 Global Transdermal Testosterone Market Size Forecast by Region

12.1.1 Global Transdermal Testosterone Forecast by Region (2023-2028)

12.1.2 Global Transdermal Testosterone Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Transdermal Testosterone Forecast by Type

12.7 Global Transdermal Testosterone Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Transdermal Testosterone Product Offered

13.1.3 AbbVie Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 Teva

13.2.1 Teva Company Information

13.2.2 Teva Transdermal Testosterone Product Offered

13.2.3 Teva Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva Main Business Overview

13.2.5 Teva Latest Developments

13.3 Perrigo

13.3.1 Perrigo Company Information

13.3.2 Perrigo Transdermal Testosterone Product Offered

13.3.3 Perrigo Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Perrigo Main Business Overview

13.3.5 Perrigo Latest Developments

13.4 Endo Pharmaceuticals

13.4.1 Endo Pharmaceuticals Company Information

13.4.2 Endo Pharmaceuticals Transdermal Testosterone Product Offered

13.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Endo Pharmaceuticals Main Business Overview

13.4.5 Endo Pharmaceuticals Latest Developments

13.5 Acerus Pharmaceuticals

13.5.1 Acerus Pharmaceuticals Company Information

13.5.2 Acerus Pharmaceuticals Transdermal Testosterone Product Offered

13.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Acerus Pharmaceuticals Main Business Overview

13.5.5 Acerus Pharmaceuticals Latest Developments

13.6 Lupin

13.6.1 Lupin Company Information

13.6.2 Lupin Transdermal Testosterone Product Offered

13.6.3 Lupin Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Lupin Main Business Overview

13.6.5 Lupin Latest Developments

13.7 Dr. Reddy's Laboratories

13.7.1 Dr. Reddy's Laboratories Company Information

13.7.2 Dr. Reddy's Laboratories Transdermal Testosterone Product Offered

13.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Dr. Reddy's Laboratories Main Business Overview

13.7.5 Dr. Reddy's Laboratories Latest Developments

13.8 Upsher-Smith Laboratories

13.8.1 Upsher-Smith Laboratories Company Information

13.8.2 Upsher-Smith Laboratories Transdermal Testosterone Product Offered

13.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Upsher-Smith Laboratories Main Business Overview

13.8.5 Upsher-Smith Laboratories Latest Developments

13.9 Allergan

13.9.1 Allergan Company Information

13.9.2 Allergan Transdermal Testosterone Product Offered

13.9.3 Allergan Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Allergan Main Business Overview

13.9.5 Allergan Latest Developments

13.10 Cipla Inc.

13.10.1 Cipla Inc. Company Information

13.10.2 Cipla Inc. Transdermal Testosterone Product Offered

13.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Cipla Inc. Main Business Overview

13.10.5 Cipla Inc. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Transdermal Testosterone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Transdermal Testosterone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Gel

Table 4. Major Players of Patch

Table 5. Global Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 6. Global Transdermal Testosterone Sales Market Share by Type (2017-2022)

Table 7. Global Transdermal Testosterone Revenue by Type (2017-2022) & ($ million)

Table 8. Global Transdermal Testosterone Revenue Market Share by Type (2017-2022)

Table 9. Global Transdermal Testosterone Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 11. Global Transdermal Testosterone Sales Market Share by Application (2017-2022)

Table 12. Global Transdermal Testosterone Revenue by Application (2017-2022)

Table 13. Global Transdermal Testosterone Revenue Market Share by Application (2017-2022)

Table 14. Global Transdermal Testosterone Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Transdermal Testosterone Sales by Company (2020-2022) & (K Units)

Table 16. Global Transdermal Testosterone Sales Market Share by Company (2020-2022)

Table 17. Global Transdermal Testosterone Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Transdermal Testosterone Revenue Market Share by Company (2020-2022)

Table 19. Global Transdermal Testosterone Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Transdermal Testosterone Producing Area Distribution and Sales Area

Table 21. Players Transdermal Testosterone Products Offered

Table 22. Transdermal Testosterone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Transdermal Testosterone Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Transdermal Testosterone Sales Market Share Geographic Region (2017-2022)

Table 27. Global Transdermal Testosterone Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Transdermal Testosterone Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Transdermal Testosterone Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Transdermal Testosterone Sales Market Share by Country/Region (2017-2022)

Table 31. Global Transdermal Testosterone Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Transdermal Testosterone Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Transdermal Testosterone Sales by Country (2017-2022) & (K Units)

Table 34. Americas Transdermal Testosterone Sales Market Share by Country (2017-2022)

Table 35. Americas Transdermal Testosterone Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Transdermal Testosterone Revenue Market Share by Country (2017-2022)

Table 37. Americas Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 38. Americas Transdermal Testosterone Sales Market Share by Type (2017-2022)

Table 39. Americas Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 40. Americas Transdermal Testosterone Sales Market Share by Application (2017-2022)

Table 41. APAC Transdermal Testosterone Sales by Region (2017-2022) & (K Units)

Table 42. APAC Transdermal Testosterone Sales Market Share by Region (2017-2022)

Table 43. APAC Transdermal Testosterone Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Transdermal Testosterone Revenue Market Share by Region (2017-2022)

Table 45. APAC Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 46. APAC Transdermal Testosterone Sales Market Share by Type (2017-2022)

Table 47. APAC Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 48. APAC Transdermal Testosterone Sales Market Share by Application (2017-2022)

Table 49. Europe Transdermal Testosterone Sales by Country (2017-2022) & (K Units)

Table 50. Europe Transdermal Testosterone Sales Market Share by Country (2017-2022)

Table 51. Europe Transdermal Testosterone Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Transdermal Testosterone Revenue Market Share by Country (2017-2022)

Table 53. Europe Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 54. Europe Transdermal Testosterone Sales Market Share by Type (2017-2022)

Table 55. Europe Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 56. Europe Transdermal Testosterone Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Transdermal Testosterone Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Transdermal Testosterone Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Transdermal Testosterone Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Transdermal Testosterone Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Transdermal Testosterone Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Transdermal Testosterone Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Transdermal Testosterone Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Transdermal Testosterone Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Transdermal Testosterone

Table 66. Key Market Challenges & Risks of Transdermal Testosterone

Table 67. Key Industry Trends of Transdermal Testosterone

Table 68. Transdermal Testosterone Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Transdermal Testosterone Distributors List

Table 71. Transdermal Testosterone Customer List

Table 72. Global Transdermal Testosterone Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Transdermal Testosterone Sales Market Forecast by Region

Table 74. Global Transdermal Testosterone Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Transdermal Testosterone Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Transdermal Testosterone Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Transdermal Testosterone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Transdermal Testosterone Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Transdermal Testosterone Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Transdermal Testosterone Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Transdermal Testosterone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Transdermal Testosterone Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Transdermal Testosterone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Transdermal Testosterone Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Transdermal Testosterone Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Transdermal Testosterone Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Transdermal Testosterone Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Transdermal Testosterone Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Transdermal Testosterone Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Transdermal Testosterone Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Transdermal Testosterone Revenue Market Share Forecast by Application (2023-2028)

Table 92. AbbVie Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 93. AbbVie Transdermal Testosterone Product Offered

Table 94. AbbVie Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. AbbVie Main Business

Table 96. AbbVie Latest Developments

Table 97. Teva Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 98. Teva Transdermal Testosterone Product Offered

Table 99. Teva Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Teva Main Business

Table 101. Teva Latest Developments

Table 102. Perrigo Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 103. Perrigo Transdermal Testosterone Product Offered

Table 104. Perrigo Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Perrigo Main Business

Table 106. Perrigo Latest Developments

Table 107. Endo Pharmaceuticals Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 108. Endo Pharmaceuticals Transdermal Testosterone Product Offered

Table 109. Endo Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Endo Pharmaceuticals Main Business

Table 111. Endo Pharmaceuticals Latest Developments

Table 112. Acerus Pharmaceuticals Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 113. Acerus Pharmaceuticals Transdermal Testosterone Product Offered

Table 114. Acerus Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Acerus Pharmaceuticals Main Business

Table 116. Acerus Pharmaceuticals Latest Developments

Table 117. Lupin Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 118. Lupin Transdermal Testosterone Product Offered

Table 119. Lupin Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Lupin Main Business

Table 121. Lupin Latest Developments

Table 122. Dr. Reddy's Laboratories Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 123. Dr. Reddy's Laboratories Transdermal Testosterone Product Offered

Table 124. Dr. Reddy's Laboratories Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Dr. Reddy's Laboratories Main Business

Table 126. Dr. Reddy's Laboratories Latest Developments

Table 127. Upsher-Smith Laboratories Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 128. Upsher-Smith Laboratories Transdermal Testosterone Product Offered

Table 129. Upsher-Smith Laboratories Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Upsher-Smith Laboratories Main Business

Table 131. Upsher-Smith Laboratories Latest Developments

Table 132. Allergan Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 133. Allergan Transdermal Testosterone Product Offered

Table 134. Allergan Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Allergan Main Business

Table 136. Allergan Latest Developments

Table 137. Cipla Inc. Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors

Table 138. Cipla Inc. Transdermal Testosterone Product Offered

Table 139. Cipla Inc. Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Cipla Inc. Main Business

Table 141. Cipla Inc. Latest Developments

List of Figures

Figure 1. Picture of Transdermal Testosterone

Figure 2. Transdermal Testosterone Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Transdermal Testosterone Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Transdermal Testosterone Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Transdermal Testosterone Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Gel

Figure 10. Product Picture of Patch

Figure 11. Global Transdermal Testosterone Sales Market Share by Type in 2021

Figure 12. Global Transdermal Testosterone Revenue Market Share by Type (2017-2022)

Figure 13. Transdermal Testosterone Consumed in Primary Hypogonadism

Figure 14. Global Transdermal Testosterone Market: Primary Hypogonadism (2017-2022) & (K Units)

Figure 15. Transdermal Testosterone Consumed in Hypogonadotropic Hypogonadism

Figure 16. Global Transdermal Testosterone Market: Hypogonadotropic Hypogonadism (2017-2022) & (K Units)

Figure 17. Transdermal Testosterone Consumed in Late-Onset Hypogonadism

Figure 18. Global Transdermal Testosterone Market: Late-Onset Hypogonadism (2017-2022) & (K Units)

Figure 19. Global Transdermal Testosterone Sales Market Share by Application (2017-2022)

Figure 20. Global Transdermal Testosterone Revenue Market Share by Application in 2021

Figure 21. Transdermal Testosterone Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Transdermal Testosterone Revenue Market Share by Company in 2021

Figure 23. Global Transdermal Testosterone Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Transdermal Testosterone Revenue Market Share by Geographic Region in 2021

Figure 25. Global Transdermal Testosterone Sales Market Share by Region (2017-2022)

Figure 26. Global Transdermal Testosterone Revenue Market Share by Country/Region in 2021

Figure 27. Americas Transdermal Testosterone Sales 2017-2022 (K Units)

Figure 28. Americas Transdermal Testosterone Revenue 2017-2022 ($ Millions)

Figure 29. APAC Transdermal Testosterone Sales 2017-2022 (K Units)

Figure 30. APAC Transdermal Testosterone Revenue 2017-2022 ($ Millions)

Figure 31. Europe Transdermal Testosterone Sales 2017-2022 (K Units)

Figure 32. Europe Transdermal Testosterone Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Transdermal Testosterone Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Transdermal Testosterone Revenue 2017-2022 ($ Millions)

Figure 35. Americas Transdermal Testosterone Sales Market Share by Country in 2021

Figure 36. Americas Transdermal Testosterone Revenue Market Share by Country in 2021

Figure 37. United States Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Transdermal Testosterone Sales Market Share by Region in 2021

Figure 42. APAC Transdermal Testosterone Revenue Market Share by Regions in 2021

Figure 43. China Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Transdermal Testosterone Sales Market Share by Country in 2021

Figure 50. Europe Transdermal Testosterone Revenue Market Share by Country in 2021

Figure 51. Germany Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Transdermal Testosterone Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Transdermal Testosterone Revenue Market Share by Country in 2021

Figure 58. Egypt Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Transdermal Testosterone Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Transdermal Testosterone in 2021

Figure 64. Manufacturing Process Analysis of Transdermal Testosterone

Figure 65. Industry Chain Structure of Transdermal Testosterone

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390